Möbius syndrome after misoprostol: a possible teratogenic mechanism

The Lancet

Volumn 346, Issue 8977, 1995, Pages 780-

  Shepard, ThomasH ^a  

^a Box 356320   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MISOPROSTOL;

ABDUCENS NERVE; ABORTION; BLOOD FLOW; EMBRYO; EMBRYO DEVELOPMENT; ENVIRONMENTAL FACTOR; FACIAL NERVE; HUMAN; INTRAVAGINAL DRUG ADMINISTRATION; LETTER; MOEBIUS SYNDROME; NERVE CELL NECROSIS; NERVE PARALYSIS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; TERATOGENICITY; ANIMAL; CONGENITAL MALFORMATION; CRANIAL NERVE; DRUG EFFECT; FEMALE; IATROGENIC DISEASE; LIMB MALFORMATION; PARALYSIS; RAT; SYNDROME; UTERUS CONTRACTION;

ABNORMALITIES, DRUG-INDUCED; ANIMAL; CRANIAL NERVES; FEMALE; HUMAN; LIMB DEFORMITIES, CONGENITAL; MISOPROSTOL; PARALYSIS; RATS; SYNDROME; UTERINE CONTRACTION;

EID: 0029091005     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(95)91540-0     Document Type: Letter

References (5)

1. Limb deficiency with and without Möbius sequence in seven Brazilian children associated with misoprostol use in the first trimester
2. Teratogenicity of misoprostol
3. Severe limb abnormalities after chorion villus sampling at 56-66 days' gestation
4. Möbius syndrome: animal model—human correlations and evidence for a brainstem vascular etiology